2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

A Retrospective Analysis of Changing From Alternative Agents to Carbamazepine Extended-Release Capsules in Bipolar Disorder

Pages 31-34 | Published online: 04 Dec 2011

References

  • Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD: Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64:53–59
  • McElroy SL, Keck PE Jr: Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 2000; 48:539–557
  • Sachs GS: Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 1996; 16(2 suppl 1):32S–47S
  • Zomberg GL, Pope HG Jr: Treatment of depression in bipolar disorder: New directions for research. J Clin Psychopharmacol 1993; 13:397–408
  • Preskorn SH: How drug-drug interactions can impact managed care. Am J Manag Care 2004; 10(6 suppl):S186—S198
  • Flowers CR, Veenstra D: The role of cost-effectiveness analysis in the era of pharmacogenomics. Pharmacoeconomics 2004; 22:481–493
  • Keck PE Jr, McElroy SL, Nemeroff CB: Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992; 4:395–405
  • Ballenger JC, Post RM: Carbamazepine in manic-depressive ill-ness: a new treatment. Am J Psychiatry 1980; 137:782–790
  • Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6:592–599
  • American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psy-chiatry 2002; 159(4 suppl):1–50
  • Weisler RH, Kalali AH, Ketter TA, and the SPD417 Study Group: A multicenter, randomized, double-blind, placebo-con-trolled trial of extended-release carbamazepine capsules as mono-therapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:478–484
  • Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA: Extended-release carbamazepine for treatment of manic and mixed symptoms. Presented at the 157th American Psychiatric Association Annual Meeting; May 1–6, 2004; New York, NY
  • Ketter TA, Kalali AH, Weisler RH, for the SPD417 Study Group: A 6-month, multicenter, open-label evaluation of extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65:668–673
  • Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter T, Keck P. Swann A, Kalali A: Efficacy of extended-release carbamazepine in bipolar disorder: results of two pooled clinical trials. Presented at the US Psychiatric and Mental Health Congress; November 18–21, 2004; San Diego, CA

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.